| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | inner ear development | 1.99e-05 | 253 | 122 | 9 | GO:0048839 | |
| GeneOntologyBiologicalProcess | developmental growth | SEMA3F EIF4H DISC1 HLA-G HLA-H APC SEMA3G ACTN3 TTC8 KMT2D CSF1 LINC-PINT EIF4G2 FGF2 KDM2A ULK1 LZTS2 | 2.61e-05 | 911 | 122 | 17 | GO:0048589 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA3F VIM SZT2 DISC1 TPRN APC SEMA3G RUNX3 TTC8 SIPA1L1 EIF4G2 IGSF9 ULK1 STRC STRCP1 | 3.60e-05 | 748 | 122 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | growth | SEMA3F EPM2A EIF4H DISC1 SLC25A33 HLA-G HLA-H APC SEMA3G ACTN3 SIPA1 TTC8 KMT2D CSF1 LINC-PINT EIF4G2 FGF2 KDM2A ULK1 LZTS2 | 3.65e-05 | 1235 | 122 | 20 | GO:0040007 |
| GeneOntologyBiologicalProcess | ear development | 5.05e-05 | 285 | 122 | 9 | GO:0043583 | |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA3F VIM SZT2 DISC1 TPRN HLA-G HLA-H APC SEMA3G RUNX3 TTC8 KANK1 PBRM1 SIPA1L1 EIF4G2 IGSF9 ULK1 STRC ALK STRCP1 | 6.36e-05 | 1285 | 122 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 6.65e-05 | 169 | 122 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SEMA3F VIM SH3RF1 DISC1 KAT6A HLA-G APC SEMA3G ACTN3 RUNX3 PBRM1 CSF1 PIAS3 EIF4G2 FGF2 SMARCD3 ULK1 TRIB1 | 7.75e-05 | 1095 | 122 | 18 | GO:0060284 |
| GeneOntologyBiologicalProcess | neuron development | SEMA3F VIM GABRR2 SZT2 DISC1 TPRN HLA-G HLA-H APC SEMA3G RUNX3 TTC8 KANK1 PBRM1 SIPA1L1 EIF4G2 IGSF9 ULK1 STRC ALK STRCP1 | 1.29e-04 | 1463 | 122 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA3F VIM SZT2 DISC1 APC SEMA3G RUNX3 TTC8 SIPA1L1 EIF4G2 IGSF9 ULK1 | 1.36e-04 | 566 | 122 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.48e-04 | 192 | 122 | 7 | GO:0050770 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 4F complex | 5.71e-05 | 13 | 125 | 3 | GO:0016281 | |
| GeneOntologyCellularComponent | RNA cap binding complex | 1.34e-04 | 17 | 125 | 3 | GO:0034518 | |
| GeneOntologyCellularComponent | HCN channel complex | 2.11e-04 | 4 | 125 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 5.68e-04 | 112 | 125 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 5.87e-04 | 64 | 125 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 7.30e-04 | 7 | 125 | 2 | GO:0032398 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA3F SH3RF1 MORN1 SZT2 LONRF1 KAT6A AKNA IRS1 LMNB2 PHC2 C6orf132 KMT2D NFATC1 NAV1 ULK1 CHPF TRIB1 HCFC1 CEP170B WNK2 | 5.68e-09 | 1105 | 130 | 20 | 35748872 |
| Pubmed | EIF4H ADAM9 IGDCC4 RUSC2 KANK1 TLE3 SIPA1L1 NAV1 ULK1 CEP170B PDZD2 | 4.12e-07 | 407 | 130 | 11 | 12693553 | |
| Pubmed | VIM CACNA1E HCN4 ADAM9 HCN3 APC LMNB2 PPFIA3 SIPA1 KANK2 PBRM1 SIPA1L1 NAV1 CEP170B WNK2 | 3.39e-06 | 963 | 130 | 15 | 28671696 | |
| Pubmed | 4.22e-06 | 9 | 130 | 3 | 18354207 | ||
| Pubmed | Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. | 4.22e-06 | 9 | 130 | 3 | 23230000 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 6.27e-06 | 69 | 130 | 5 | 28481362 | |
| Pubmed | 8.24e-06 | 11 | 130 | 3 | 17442941 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | VIM SIPA1 PHC2 RUSC2 PIAS3 SIPA1L1 ERI3 NUP133 IGSF9 LZTS2 PYCR3 | 8.85e-06 | 560 | 130 | 11 | 21653829 |
| Pubmed | [Expression of Livin in laryngeal squamous cell carcinoma and relationship with bFGF]. | 1.39e-05 | 2 | 130 | 2 | 18476630 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 31114072 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 34910522 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28978472 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 33885248 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15247275 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 7999082 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 32581014 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11687802 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15016848 | ||
| Pubmed | Variants in HCFC1 and MN1 genes causing intellectual disability in two Pakistani families. | 1.39e-05 | 2 | 130 | 2 | 38956580 | |
| Pubmed | Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration. | 1.39e-05 | 2 | 130 | 2 | 21317457 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16878150 | ||
| Pubmed | UIMC1 TPRN KANK1 KMT2D PBRM1 PIAS3 EIF4G2 KDM2A LZTS2 CHPF EPN1 | 1.46e-05 | 591 | 130 | 11 | 15231748 | |
| Pubmed | 2.08e-05 | 503 | 130 | 10 | 16964243 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | VIM SH3RF1 APC IRS1 C6orf132 RUSC2 PTOV1 MLXIPL SIPA1L1 NAV1 EIF4G3 CEP170B SEC23B | 2.19e-05 | 861 | 130 | 13 | 36931259 |
| Pubmed | VIM APC ZC3HC1 ACTN3 PPFIA3 SIPA1 KANK2 MLXIPL SACS RBMX SIPA1L1 EIF4G2 NAV1 EIF4G3 CEP170B WNK2 CACNA2D3 | 2.54e-05 | 1431 | 130 | 17 | 37142655 | |
| Pubmed | 2.76e-05 | 16 | 130 | 3 | 33253712 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 PATL1 PHC2 PCF11 KMT2D TLE3 RBMX SIPA1L1 EIF4G2 DYNC1LI1 MN1 CCDC9 | 3.56e-05 | 774 | 130 | 12 | 15302935 |
| Pubmed | VIM CACNA1E SLC25A33 APC PPFIA3 SIPA1L1 MYO1F DYNC1LI1 CEP170B | 3.66e-05 | 430 | 130 | 9 | 32581705 | |
| Pubmed | The expression of selected molecular markers of immune tolerance in psoriatic patients. | 4.15e-05 | 3 | 130 | 2 | 29790686 | |
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 4.15e-05 | 3 | 130 | 2 | 30801007 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 28007623 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 12748172 | ||
| Pubmed | Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. | 4.15e-05 | 3 | 130 | 2 | 19470943 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 24447545 | ||
| Pubmed | TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression. | 4.15e-05 | 3 | 130 | 2 | 30679431 | |
| Pubmed | CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function. | 4.15e-05 | 3 | 130 | 2 | 33188139 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 39129034 | ||
| Pubmed | NFAT regulates CSF-1 gene transcription triggered by L-selectin crosslinking. | 4.15e-05 | 3 | 130 | 2 | 20925194 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 32593225 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 32024448 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 10542332 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 26739330 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 29183992 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 14507913 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 20123002 | ||
| Pubmed | A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. | 4.15e-05 | 3 | 130 | 2 | 11172724 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PSMF1 MORN1 KAT6A PATL1 TTC8 NFATC1 TLE3 ERI3 NAV1 SLC9A7 IGSF9 KDM2A LZTS2 EIF4G3 CEP170B WNK2 PDZD2 | 4.18e-05 | 1489 | 130 | 17 | 28611215 |
| Pubmed | p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. | 4.73e-05 | 19 | 130 | 3 | 16105984 | |
| Pubmed | 5.12e-05 | 347 | 130 | 8 | 17114649 | ||
| Pubmed | SH3RF1 TPRN HCN3 KAT6A APC KANK1 NFATC1 EIF4G2 LZTS2 PLEKHH2 CHPF | 5.88e-05 | 689 | 130 | 11 | 36543142 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 6.36e-05 | 462 | 130 | 9 | 31138677 | |
| Pubmed | 6.46e-05 | 21 | 130 | 3 | 22479202 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 7.00e-05 | 184 | 130 | 6 | 32908313 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 16043489 | ||
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 8.28e-05 | 4 | 130 | 2 | 18849963 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 9405696 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 12928435 | ||
| Pubmed | Kank proteins: a new family of ankyrin-repeat domain-containing proteins. | 8.28e-05 | 4 | 130 | 2 | 17996375 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 20140458 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 8.28e-05 | 4 | 130 | 2 | 9630217 | |
| Pubmed | Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. | 8.28e-05 | 4 | 130 | 2 | 20820800 | |
| Pubmed | Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT. | 8.28e-05 | 4 | 130 | 2 | 19338776 | |
| Pubmed | KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. | 8.28e-05 | 4 | 130 | 2 | 25961457 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 19805226 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 19554261 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 21615589 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 17916629 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 22704062 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 18511911 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DUSP9 HIC2 LMNB2 KANK2 KMT2D NFATC1 TLE3 RBMX NUP133 KDM2A TRIB1 HCFC1 | 9.39e-05 | 857 | 130 | 12 | 25609649 |
| Pubmed | ATP8B3 ADAM9 KAT6A APC IRS1 SEMA3G KDM2A ULK1 HCFC1 SEC23B WNK2 | 9.80e-05 | 730 | 130 | 11 | 34857952 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | EIF4H CWC15 APC PATL1 KANK2 PCF11 KANK1 PBRM1 RBMX NUP133 DYNC1LI1 CCDC9 HCFC1 CEP170B | 1.12e-04 | 1155 | 130 | 14 | 20360068 |
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 1.19e-04 | 67 | 130 | 4 | 22321011 | |
| Pubmed | 1.33e-04 | 130 | 130 | 5 | 12421765 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 1.38e-04 | 5 | 130 | 2 | 15564593 | |
| Pubmed | Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome. | 1.38e-04 | 5 | 130 | 2 | 24797007 | |
| Pubmed | MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. | 1.38e-04 | 5 | 130 | 2 | 17403683 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 9174053 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 34429357 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 24711622 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 18818766 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 12431995 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 27497248 | ||
| Pubmed | Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. | 1.38e-04 | 5 | 130 | 2 | 9878069 | |
| Pubmed | PNUTS forms a trimeric protein complex with GABA(C) receptors and protein phosphatase 1. | 1.38e-04 | 5 | 130 | 2 | 18325784 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 8633037 | ||
| Pubmed | HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP. | 1.38e-04 | 5 | 130 | 2 | 31227231 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 24920589 | ||
| Pubmed | 1.41e-04 | 209 | 130 | 6 | 36779422 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.49e-04 | 71 | 130 | 4 | 28319113 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.70e-04 | 137 | 130 | 5 | 37039823 | |
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 2.06e-04 | 6 | 130 | 2 | 30537346 | |
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 2.06e-04 | 6 | 130 | 2 | 6420070 | |
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 2.06e-04 | 6 | 130 | 2 | 6276751 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 9730897 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 18296638 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 6411351 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 2.06e-04 | 6 | 130 | 2 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 2.06e-04 | 6 | 130 | 2 | 3940270 | |
| GeneFamily | Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing | 1.40e-04 | 4 | 88 | 2 | 623 | |
| GeneFamily | PHD finger proteins | 9.73e-04 | 90 | 88 | 4 | 88 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.03e-03 | 10 | 88 | 2 | 250 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | VIM SH3RF1 EIF4H LONRF1 ADAM9 HIC2 KANK2 RUSC2 TLE3 SIPA1L1 EIF4G2 MYO1F SLC9A7 SMARCD3 ULK1 MTX1 EPN1 PCDHGC3 TRIB1 INO80B | 3.17e-06 | 1250 | 129 | 20 | M41099 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 130 | 7 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 2.06e-06 | 200 | 130 | 7 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-06 | 148 | 130 | 6 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.91e-06 | 161 | 130 | 6 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.19e-06 | 162 | 130 | 6 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 167 | 130 | 6 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 172 | 130 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 175 | 130 | 6 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 175 | 130 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-05 | 116 | 130 | 5 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-05 | 196 | 130 | 6 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-05 | 196 | 130 | 6 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-05 | 197 | 130 | 6 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | mLN-(2)_B_cell-(20)_B_cell_IgA_Plasma|mLN / shred on region, Cell_type, and subtype | 2.48e-05 | 197 | 130 | 6 | a39b384ee9824a08c3b544a9c3c7f0f95f08d6a7 | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|mLN / Region, Cell class and subclass | 2.48e-05 | 197 | 130 | 6 | 20822fce311326765b71337ce501ba44ea14f58f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 198 | 130 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.55e-05 | 198 | 130 | 6 | 1a189b2b213099505c5d871fb8aedd55a97d44e0 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 2.63e-05 | 199 | 130 | 6 | 3e14f9a62d6414add8d5f681be184b4625001838 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 2.63e-05 | 199 | 130 | 6 | bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3-NKT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 846d3f0e647040d0e372df0dfcd69a21d5da5aea | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.70e-05 | 200 | 130 | 6 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | c70f06b243ae9804f97308ee02b4b5e1a4a6f9f3 | |
| ToppCell | wk_20-22-Mesenchymal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 200 | 130 | 6 | 5c8557d2c414d8a8c518270f8c045b53cae45fb6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 4.78e-05 | 135 | 130 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.31e-05 | 138 | 130 | 5 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-05 | 140 | 130 | 5 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-05 | 143 | 130 | 5 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.21e-05 | 155 | 130 | 5 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 156 | 130 | 5 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 158 | 130 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 158 | 130 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 1.31e-04 | 167 | 130 | 5 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.31e-04 | 167 | 130 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 168 | 130 | 5 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.34e-04 | 168 | 130 | 5 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-04 | 169 | 130 | 5 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.38e-04 | 169 | 130 | 5 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 1.38e-04 | 169 | 130 | 5 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | -SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.42e-04 | 170 | 130 | 5 | 601630644f09133ee4c5e64499460b55cf3e80a0 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.42e-04 | 170 | 130 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 1.46e-04 | 171 | 130 | 5 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-04 | 174 | 130 | 5 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 1.63e-04 | 175 | 130 | 5 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 175 | 130 | 5 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-04 | 178 | 130 | 5 | c4a2e9a440e941e82bb35abefa054e07ad250d45 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 178 | 130 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 179 | 130 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 180 | 130 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.95e-04 | 182 | 130 | 5 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 182 | 130 | 5 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 183 | 130 | 5 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 183 | 130 | 5 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 183 | 130 | 5 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 183 | 130 | 5 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 2.00e-04 | 183 | 130 | 5 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 183 | 130 | 5 | c5e90577b57a86c06afdf89d4b519b3694f813f9 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 183 | 130 | 5 | 8ef5223e46f1fd81a856261248cc77e7c7e72ef6 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.10e-04 | 185 | 130 | 5 | 9f330f254ee3ce47e1dd1155f2d16fa262ca89b2 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 185 | 130 | 5 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-04 | 186 | 130 | 5 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 187 | 130 | 5 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 187 | 130 | 5 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 187 | 130 | 5 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 187 | 130 | 5 | e4cb79c7aa29e8c99d5a3a209d2f9a03c2ba9bb7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-04 | 188 | 130 | 5 | 239bec13476dd43bebc2c6eba8d1fe35f2744673 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 189 | 130 | 5 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 189 | 130 | 5 | c38157c8cf5c0c1f560011ef5cc5892a049ee2b7 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 189 | 130 | 5 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 189 | 130 | 5 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.32e-04 | 189 | 130 | 5 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 189 | 130 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 190 | 130 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-04 | 190 | 130 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 190 | 130 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 190 | 130 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-04 | 190 | 130 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 191 | 130 | 5 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-04 | 191 | 130 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-04 | 191 | 130 | 5 | 5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 191 | 130 | 5 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 192 | 130 | 5 | ce867b6e78c1d8f30dff81bf572a78a897bc7625 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 192 | 130 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 192 | 130 | 5 | 58a7829b411b02b422ef75e2277a868969cc23e8 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 192 | 130 | 5 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 192 | 130 | 5 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 192 | 130 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | NS-control-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.50e-04 | 192 | 130 | 5 | ef252dd9df161f665f53c047c0514381f80d6683 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 192 | 130 | 5 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | control-Lymphoid-Treg|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.50e-04 | 192 | 130 | 5 | 9067e90b7c2d734100d6e5026d753113bf9428a3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 192 | 130 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.56e-04 | 193 | 130 | 5 | e325cf49e159c6be205ed93adaa09efdd0c122b4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-04 | 193 | 130 | 5 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-04 | 193 | 130 | 5 | 1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6 | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 1.38e-05 | 196 | 126 | 8 | 6602_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 1.43e-05 | 197 | 126 | 8 | 7259_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 3882_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.54e-05 | 199 | 126 | 8 | 7128_DN | |
| Drug | Spaglumic acid [4910-46-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 126 | 8 | 7465_UP | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.81e-05 | 2 | 126 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | citrate measurement | 2.29e-05 | 79 | 126 | 5 | EFO_0010114 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 4.95e-05 | 17 | 126 | 3 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 4.95e-05 | 17 | 126 | 3 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 4.95e-05 | 17 | 126 | 3 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 4.95e-05 | 17 | 126 | 3 | C0751780 | |
| Disease | May-White Syndrome | 4.95e-05 | 17 | 126 | 3 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 4.95e-05 | 17 | 126 | 3 | C0751781 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 5.92e-05 | 18 | 126 | 3 | C0751779 | |
| Disease | Neural crest tumor | 3.75e-04 | 7 | 126 | 2 | C2931189 | |
| Disease | heart rate | 4.23e-04 | 225 | 126 | 6 | EFO_0004326 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.82e-04 | 239 | 126 | 6 | EFO_0010934 | |
| Disease | phosphoglycerides measurement | 1.14e-03 | 48 | 126 | 3 | EFO_0022291 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.16e-03 | 12 | 126 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.34e-03 | 189 | 126 | 5 | EFO_0009932 | |
| Disease | coagulation factor X measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0020265 | |
| Disease | glycoprotein measurement | 1.72e-03 | 119 | 126 | 4 | EFO_0004555 | |
| Disease | BMI-adjusted adiponectin measurement | 1.83e-03 | 15 | 126 | 2 | EFO_0007737 | |
| Disease | cryptococcosis | 1.83e-03 | 15 | 126 | 2 | EFO_0007229 | |
| Disease | low density lipoprotein particle size measurement | 1.98e-03 | 58 | 126 | 3 | EFO_0008593 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.19e-03 | 127 | 126 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Lipidemias | 2.36e-03 | 17 | 126 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 2.36e-03 | 17 | 126 | 2 | C0020473 | |
| Disease | phospholipids in large VLDL measurement | 2.39e-03 | 62 | 126 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 2.39e-03 | 62 | 126 | 3 | EFO_0022313 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 2.65e-03 | 18 | 126 | 2 | DOID:1273 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.69e-03 | 222 | 126 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Coronary Arteriosclerosis | 2.74e-03 | 65 | 126 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 2.74e-03 | 65 | 126 | 3 | C1956346 | |
| Disease | chronic obstructive pulmonary disease | 2.84e-03 | 688 | 126 | 9 | EFO_0000341 | |
| Disease | total lipids in large VLDL | 2.98e-03 | 67 | 126 | 3 | EFO_0022175 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.03e-03 | 139 | 126 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 3.03e-03 | 139 | 126 | 4 | C0007621 | |
| Disease | fatty acid measurement, linoleic acid measurement | 3.11e-03 | 68 | 126 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.11e-03 | 68 | 126 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 3.11e-03 | 68 | 126 | 3 | EFO_0022265 | |
| Disease | total blood protein measurement | 3.23e-03 | 449 | 126 | 7 | EFO_0004536 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.24e-03 | 69 | 126 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | maximal midexpiratory flow rate | 3.27e-03 | 20 | 126 | 2 | EFO_0004313 | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.59e-03 | 713 | 126 | 9 | EFO_0005689 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.66e-03 | 72 | 126 | 3 | EFO_0022336 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.69e-03 | 239 | 126 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | phospholipids in large HDL measurement | 3.80e-03 | 73 | 126 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 3.95e-03 | 74 | 126 | 3 | EFO_0022189 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MATASPAADGGRGRP | 1 | O43414 | |
| MARFGEAVVARPGSG | 1 | Q15878 | |
| SRGPAFPGMGSEELR | 76 | Q96CA5 | |
| MGTGPAQTPRSTRAG | 1 | O60423 | |
| MTTAARPTFEPARGG | 1 | Q9P013 | |
| RQRLGGVGAGSRPPM | 751 | A1A5B4 | |
| GPTDMGRGEPVRRSA | 1016 | Q9Y4F5 | |
| MRSSTGPGIGFLSPA | 46 | Q9NRI5 | |
| MGPAEAGRRGAASPV | 1 | Q4G0W2 | |
| FKMGARTEVGPGPFS | 921 | Q8TDY8 | |
| MSSVFGKPRAGSGPQ | 1 | Q9NYN1 | |
| APSGPVRSSSGMGGR | 166 | P38159 | |
| MSRPGAGEPRFISVG | 36 | P01893 | |
| VSRPGRGEPRFIAMG | 36 | P17693 | |
| MAAAGEGTPSSRGPR | 1 | Q5T089 | |
| SMAREPGGRSPAFVQ | 1196 | P51610 | |
| MVRGAGPGPSLSALS | 1 | Q6ZTZ1 | |
| FGRLGSFPVRGTPMA | 621 | Q8WUM0 | |
| RMSPSQFARVPGFVG | 276 | Q86TB9 | |
| SASPRAGTPVGALMG | 1451 | Q86U86 | |
| MRFRFGVVVPPAVAG | 1 | O95278 | |
| GSRFRDGPPLRGSNM | 181 | Q15056 | |
| LPSFMGPRATGLSGS | 161 | Q9BRK4 | |
| MTASAQPRGRRPGVG | 1 | Q9NV35 | |
| RAAATMATPLPGRAG | 16 | Q03252 | |
| KGRMGPPGRDSSSLA | 776 | O75145 | |
| VARTSPGGSREMAPA | 6 | Q17RB8 | |
| SGMVPRGPTATARFG | 66 | Q9UJY1 | |
| RAGSRAMKPPGGESS | 11 | Q9H910 | |
| MAAVGRVGSFGSSPP | 1 | Q9Y6G9 | |
| ASLFIGSFPGMRRPG | 161 | Q8NA75 | |
| VPGRPGSVTFMRGDK | 386 | A6NNH2 | |
| GDSPFTIRTEVMGGP | 51 | Q3V5L5 | |
| IVFPSGMGTSSPARR | 251 | Q15116 | |
| SARSPSGMLRGAPGG | 11 | A0A455ZAR2 | |
| RAMLARTYGPGPSAG | 11 | P53370 | |
| MSDSRGVPRNSIPGG | 2191 | O15018 | |
| FRIGPSSPSNGIDMG | 331 | Q8IYU2 | |
| RGRSAAMSGPEPGSP | 61 | O15503 | |
| TLGPAPRAGGTMKSA | 26 | O95644 | |
| GVSGFGVPPASMRRA | 216 | Q9BUN8 | |
| SLAGRAGSSMAPVPG | 141 | Q99956 | |
| PGEFRRPRLASFGGM | 176 | Q14678 | |
| PMVGSGRLGAPVGRS | 251 | Q96S07 | |
| RPGGSSVEMLPRGTS | 571 | Q9UN70 | |
| RKRSEPSPGSSGGIM | 556 | Q9P1Z3 | |
| TSPASMVGGKPGSFR | 311 | P35568 | |
| GPGVIQDRFSPTMGR | 386 | P78344 | |
| SPAMRGGARGRPQLT | 56 | Q8NDY4 | |
| ESMAAFPLFPRAGGG | 1111 | Q9Y3Q4 | |
| MSPGASRGPRGSQAP | 1 | P53708 | |
| GPGSPRAMKRGVSLS | 646 | Q8IVE3 | |
| RRGSTSGAMEAPEPG | 6 | Q9C086 | |
| MAVRQAATAGTPGPR | 1 | Q5TIA1 | |
| ARSAPPMEGARVFGA | 51 | Q86YD1 | |
| MRFEGPSVPGGGLRI | 1006 | O94913 | |
| GRSPSAVAMQAGPRA | 1876 | Q92794 | |
| PGGPEMRRVNSAGRA | 1096 | Q5T0Z8 | |
| ASFPRGMNPTGTGAV | 96 | P0CG12 | |
| DFAMRPGFGGSPVPV | 71 | A8MPY1 | |
| PRFHGRVGFTGTMPA | 86 | Q5DX21 | |
| SPRGMVTRSSPGAGP | 731 | Q9Y2K7 | |
| SRPGGGSMQTEPARP | 326 | P09603 | |
| MAGPGSPRRASRGAS | 1 | Q8IZS8 | |
| PPQQGGRAGMGRASR | 96 | Q9Y3X0 | |
| PIRSPAMSGGIFAIR | 301 | Q7Z4T8 | |
| PDGRTGGSVARATPM | 246 | Q7Z591 | |
| MGSGARFPSGTLRVR | 1 | Q13443 | |
| METGGRARTGTPQPA | 1 | Q5VV63 | |
| VMTPLPGGHAAGRTR | 41 | Q6ZN54 | |
| VPARSPGAFDMSGVR | 431 | Q9Y6I3 | |
| SRPGPAGTMAAGSIT | 126 | P09038 | |
| GTGGPPAGVRSIMKR | 471 | Q63ZY3 | |
| ASVSPAARGGPMASR | 26 | Q96LR7 | |
| GPAPVSSRGRTLAMA | 141 | Q9H228 | |
| PGATSISPGRMFRDL | 2656 | Q9NZJ4 | |
| LPSATARPNTFMRGG | 1141 | O43432 | |
| RMVRAPVGSAPGTSF | 201 | Q5SRE7 | |
| FSMRPAFGGPAIPVG | 66 | P28476 | |
| FGPRRGGMIVDPLRS | 201 | Q92530 | |
| GGMIVDPLRSGFPRA | 206 | Q92530 | |
| GMRRTRPGTSAPAAA | 361 | Q3SYA9 | |
| GMRRTRPGTSAPAAA | 591 | A6NNC1 | |
| PGGAFPGASAMPRAA | 266 | Q10571 | |
| ATPARAPGTRTLGMA | 446 | Q13505 | |
| SMSVTGGRGGPRPVS | 681 | Q8NEY1 | |
| AGSTGMGRPPRSQRL | 151 | Q96JB3 | |
| AVGPGGRARPEVRSM | 41 | Q13761 | |
| MAGPGSPPRRVTSFA | 531 | Q8N2Y8 | |
| PRAMAILGTEGRGSF | 2946 | Q5T011 | |
| GMPAPGASLALRVSF | 6 | O60522 | |
| GSRATDGALRPMPTA | 166 | Q13275 | |
| GDGTRVGMGARTPRP | 161 | Q7L2K0 | |
| VGMGARTPRPGAGLR | 166 | Q7L2K0 | |
| MGRGARVPSEAPGAG | 1 | O75900 | |
| FLVHGVRPGMPSGAR | 21 | Q6STE5 | |
| AASGIMGRSALPRPS | 511 | Q8ND83 | |
| MPEGFGVSRRSPASI | 1171 | O43166 | |
| GGVGSPRRGMAPAST | 6 | Q96FS4 | |
| RRLSGDLSSMPGPGT | 611 | Q9NP71 | |
| MRPISGVTLGAFGGA | 471 | Q96PQ1 | |
| FRGMGSPLPASALVS | 721 | Q96KW2 | |
| MAAAEPSPRRVGFVG | 1 | Q53H96 | |
| PSPRRVGFVGAGRMA | 6 | Q53H96 | |
| ISSSFEPGRMGEGPV | 66 | Q7RTU9 | |
| FPNTGARIMLFTGGP | 281 | Q15437 | |
| GAGMVRPTSVTPGLF | 61 | Q9BSK2 | |
| GATAAAAAAGMGPRP | 416 | Q7Z6J0 | |
| RGVTMVSPSTAGGPA | 526 | Q7Z6J0 | |
| GPGAERSKEMPRGSF | 306 | Q9UM73 | |
| RRMVPYKGSGAPAGA | 871 | Q08043 | |
| SPVPMGSFPRRGFVN | 111 | P25054 | |
| LTGARGRRAPPGMAV | 151 | Q8IZ52 | |
| GEARVGAGFRPMLPS | 141 | Q9Y242 | |
| PSSVLRSPAMGTLGG | 491 | Q9Y6X2 | |
| RPVTRSMGTGDTPGL | 376 | Q86WB0 | |
| PGSMEGRAGLSRTVP | 301 | Q8IXK0 | |
| GFLRPSTQSGRPGTM | 121 | Q8TAM2 | |
| VRSAMSGASQPRGPA | 6 | Q96RU8 | |
| PCRFRGFEVMGNPGT | 36 | Q96DB5 | |
| YRRMFGGPGTASRPS | 11 | P08670 | |
| CRGPDGRFVMGPTVA | 846 | Q9P2J2 | |
| SSMALARGPGRPAVS | 146 | Q15561 | |
| GRSPMVSFGAVGFDP | 411 | Q04726 | |
| MAALGRPGSGPRAAV | 1 | Q4KMQ1 | |
| MGPAGVAARPGRFFG | 1 | Q9BQ83 | |
| LGREAMIFRSGGPRP | 196 | Q9NS98 | |
| ISSSFEPGRMGEGPV | 66 | A6NGW2 | |
| RAGSLGPETPSRVGM | 1886 | Q9Y3S1 | |
| MEPGDAARPGSGRAT | 1 | Q96T83 | |
| RSTPLTATPGGRGDM | 96 | Q9UEU0 | |
| TGAFRVPSPGMEEAG | 646 | Q96RL1 | |
| AEMRGGRSPRPGSSA | 526 | O75385 | |
| PQGPRTRMFSAGPTG | 766 | O75385 | |
| SSIPRGREKAGPMGS | 376 | Q8N5Q1 | |
| SPGTGAFVGTPSPMR | 2521 | O14686 | |
| RIPTVDGRPRGTSGM | 196 | Q9P206 | |
| RGMDRNGVPPSARGG | 951 | O00160 |